NO20040031L - Aryl-(eller heteroaryl)azolylkarbynolderivater for behandlingen av urininkontinens - Google Patents

Aryl-(eller heteroaryl)azolylkarbynolderivater for behandlingen av urininkontinens

Info

Publication number
NO20040031L
NO20040031L NO20040031A NO20040031A NO20040031L NO 20040031 L NO20040031 L NO 20040031L NO 20040031 A NO20040031 A NO 20040031A NO 20040031 A NO20040031 A NO 20040031A NO 20040031 L NO20040031 L NO 20040031L
Authority
NO
Norway
Prior art keywords
heteroaryl
aryl
derivatives
treatment
azolylcarbynol
Prior art date
Application number
NO20040031A
Other languages
English (en)
Inventor
Merce-Vidal Ramon
Andaluz-Mataro Blas
Frigola-Constansa Jordi
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO20040031L publication Critical patent/NO20040031L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivativer av aryl(eller heteroaryl)azolylkarbinoler med generell formel (I), hvori Ar representerer et fenylradikal eller et tienylradikal, valgfritt substitutert, Ri representerer et hydrogenatom eller en lavere alkylgruppe, Rrepresenterer et dialkylaminoalkyl eller azaheterocyklylalkyl og Het representerer et azol usubstitutert eller valgfritt substitutert med én eller to substituenter og deres fysiologisk akseptable salter; er anvendelige som medikamenter i humane og/eller dyreterapeutika for å behandle inkontinens i pattedyr, inklusive menneske.
NO20040031A 2001-07-06 2004-01-05 Aryl-(eller heteroaryl)azolylkarbynolderivater for behandlingen av urininkontinens NO20040031L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101587A ES2180449B1 (es) 2001-07-06 2001-07-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
PCT/ES2002/000326 WO2003004022A1 (es) 2001-07-06 2002-07-01 Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria

Publications (1)

Publication Number Publication Date
NO20040031L true NO20040031L (no) 2004-03-02

Family

ID=8498326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040031A NO20040031L (no) 2001-07-06 2004-01-05 Aryl-(eller heteroaryl)azolylkarbynolderivater for behandlingen av urininkontinens

Country Status (23)

Country Link
US (2) US20030022925A1 (no)
EP (1) EP1413305B1 (no)
JP (1) JP2004521150A (no)
KR (1) KR20040030788A (no)
CN (1) CN1543344A (no)
AR (1) AR034679A1 (no)
AT (1) ATE327752T1 (no)
BR (1) BR0211237A (no)
CA (1) CA2452646A1 (no)
CY (1) CY1105113T1 (no)
DE (1) DE60211913T2 (no)
DK (1) DK1413305T3 (no)
ES (2) ES2180449B1 (no)
MA (1) MA27056A1 (no)
MX (1) MXPA04000065A (no)
NO (1) NO20040031L (no)
NZ (1) NZ530817A (no)
PL (1) PL369062A1 (no)
PT (1) PT1413305E (no)
RU (1) RU2308268C2 (no)
UA (1) UA79238C2 (no)
WO (1) WO2003004022A1 (no)
ZA (1) ZA200400780B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040142929A1 (en) * 2001-07-06 2004-07-22 Ramon Merce-Vidal Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US20060040924A1 (en) * 2004-06-22 2006-02-23 Laboratorios Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of renal colic
WO2006010627A1 (en) * 2004-07-30 2006-02-02 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1743892A1 (en) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743890A1 (en) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments
US7897589B2 (en) * 2005-07-15 2011-03-01 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
EP1757587A1 (en) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, their preparation and use as medicaments
US20070021485A1 (en) * 2005-07-22 2007-01-25 Gomis Antonio F Aryl (or heteroaryl) azolylcarbinols
ES2334548B1 (es) * 2005-07-29 2010-10-27 Laboratorios Del Dr. Esteve, S.A Forma de dosificacion de liberacion controlada de compuestos de pirazol para el tratamiento de la incontinencia urinaria.
US8722079B2 (en) 2008-04-18 2014-05-13 Warsaw Orthopedic, Inc. Methods for treating conditions such as dystonia and post-stroke spasticity with clonidine
EP2151234A1 (en) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion
US20100291151A1 (en) * 2009-04-21 2010-11-18 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE891865A (fr) * 1981-01-30 1982-07-22 Sandoz Sa Nouveaux medicaments a base de derives condenses de l'imidazole pour le traitement des troubles urinaires
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
JP2004521150A (ja) 2004-07-15
RU2308268C2 (ru) 2007-10-20
KR20040030788A (ko) 2004-04-09
ES2180449B1 (es) 2004-01-16
RU2004103475A (ru) 2005-06-10
NZ530817A (en) 2005-07-29
PL369062A1 (en) 2005-04-18
ES2263792T3 (es) 2006-12-16
ATE327752T1 (de) 2006-06-15
EP1413305B1 (en) 2006-05-31
US20030022925A1 (en) 2003-01-30
CA2452646A1 (en) 2003-01-16
BR0211237A (pt) 2004-08-10
DE60211913D1 (de) 2006-07-06
ZA200400780B (en) 2005-01-31
MXPA04000065A (es) 2004-05-21
EP1413305A1 (en) 2004-04-28
DK1413305T3 (da) 2006-09-18
MA27056A1 (fr) 2004-12-20
ES2180449A1 (es) 2003-02-01
CN1543344A (zh) 2004-11-03
UA79238C2 (en) 2007-06-11
CY1105113T1 (el) 2010-03-03
DE60211913T2 (de) 2007-05-24
US20050131049A1 (en) 2005-06-16
WO2003004022A1 (es) 2003-01-16
PT1413305E (pt) 2006-09-29
AR034679A1 (es) 2004-03-03

Similar Documents

Publication Publication Date Title
CY1105113T1 (el) Παραγωγα της αρυλικης (ή ετepοαρυλικης) αζολυλκαρβυνολης για την αντιμετωπιση της ακρατειας ουρων
NO20054082L (no) Pyrazol`1,5-A! 1,3,5! triazinderivater som kannabinoidreseptorligander
MX2007003321A (es) Derivados heterociclicos y su uso como agentes terapeuticos.
ATE537830T1 (de) Nicotinamid derivate und ihre verwendung als therapeutika
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
TW200626592A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en) Heterocyclic derivatives and their use as therapeutic agents
WO2006101521A3 (en) Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
TW200624427A (en) Heterocyclic derivatives and their use as therapeutic agents
ATE402697T1 (de) 1,3,5-trisubstituierte 4,5-dihydro-1h-pyrazol- derivative mit cb1-antagonistischer aktivität
NO20060971L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
TW200626153A (en) Heterocyclic derivatives and their use as therapeutic agents
NO20054852L (no) GFAT inhibitorer
DE60217118D1 (de) 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer
NO20060147L (no) Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav
ATE430743T1 (de) Benzimidazolsubstituierte thiophenderivate, die auf ikk3 wirken
ATE443990T1 (de) 3-heteroarylsubstituierte 5-methyloxymethyl- isoxazoline als herbizide
ATE353646T1 (de) Verwendung von indol- und indolin-derivaten bei der behandlung von adipositas oder zur reduzierung der nahrungsaufnahme
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MY139676A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20013409L (no) Anvendelse av pyrimidin-derivater for forhindring og behandling av cerebral ischemi
NO20022123L (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO20062307L (no) Spirofuropyridinarylderivater
ES2174756A1 (es) Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application